← Leaderboards
Luke Franklin Pennington
Stanford University
$115,242
Attributed
$115,242
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $39.3K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$115,242 · 1
By mechanism
F30$115,242 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Stephen J Galli$26,066,229
- R. Sharon Chinthrajah$3,711,935
- Kari C. Nadeau$30,132,783
- Taia Wang$9,240,417
- Michelle Louise James$4,919,512
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteAllergicAffinityAllergic ResponseAnaphylaxisAnkyrin RepeatAllergic DiseaseAntibodiesAntibody LibrariesAntigensAnti-IgeAutoimmune DiseasesBaseBasophilsBindingBinding SitesCellsCessation Of LifeComplexConflict (Psychology)CountryCrystallizationDesignDissociation
Grant awards (3)
Disrupting IgE:FceR1a Interactions: Novel Therapies for Allergic Disease$39,293
F30 · FY2019 · AI · contact PI
Disrupting IgE:FceR1a Interactions: Novel Therapies for Allergic Disease$38,405
F30 · FY2018 · AI · contact PI
Disrupting IgE:FceR1a Interactions: Novel Therapies for Allergic Disease$37,544
F30 · FY2017 · AI · contact PI